The Online Investor
Computers M&A image Computers M&A » By The Online Investor Staff, updated Sun., Apr. 11, 9:32 PM Recent mergers and acquisitions in the Computers M&A category.

Slide #18. Omnicell, Inc. SurgiChem Limited

Acquirer: Omnicell, Inc. (NASDAQ:OMCL)
Acquiree: SurgiChem Limited
Details: Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced that it has signed an agreement with Bupa Care Homes (CFG) plc to purchase the entire outstanding share capital of SurgiChem Limited, a wholly-owned subsidiary of Bupa, for 12,000,000 subject to certain adjustments, in a cash transaction.

Omnicell is a provider of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Co. provides a range of automation, including robotics designed to digitize and streamline workflows and reduce human error in central pharmacy and clinical areas, and to support medication adherence initiatives in retail pharmacies. Co.'s automation products and services include central pharmacy automation solutions for both dispensing and IV compounding systems, medication and supply dispensing systems at the point of care, as well as medication adherence solutions which are used by retail, community, and outpatient pharmacies.

OMCL SEC Filing Email Alerts Service

Open the OMCL Page at The Online Investor »

Company Name: 
Omnicell Inc
Application Software
Number of ETFs Holding OMCL: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the OMCL Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Strong Buy (3.50 out of 4)
56th percentile
(ranked higher than approx. 56% of all stocks covered)

Analysts' Target Price:
OMCL Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Computers M&A - Slide 18 of 68 Page |

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.